Brown Brothers Harriman & CO Amgen Inc Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Amgen Inc stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 20,393 shares of AMGN stock, worth $5.37 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

20,393

Previous 20,452 0.29%

Holding current value

$5.37 Million

Previous $6.39 Million 2.82%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $18,253 - $19,905	-59 Reduced 0.29%	20,393 $6.57 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $934,076 - $1.14 Million	3,555 Added 21.04%	20,452 $6.39 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $64,797 - $78,218	241 Added 1.45%	16,897 $4.8 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $41,167 - $46,442	161 Added 0.98%	16,656 $4.8 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $16,180 - $20,088	-74 Reduced 0.45%	16,495 $4.43 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $8,785 - $10,388	41 Added 0.25%	16,569 $3.68 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $38,158 - $46,508	-169 Reduced 1.01%	16,528 $4 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $201,546 - $256,088	-880 Reduced 5.01%	16,697 $4.39 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $103,027 - $116,195	-459 Reduced 2.54%	17,577 $3.96 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $226,326 - $251,861	981 Added 5.75%	18,036 $4.39 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $33,329 - $36,870	152 Added 0.9%	17,055 $4.12 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $155,524 - $177,983	782 Added 4.85%	16,903 $3.8 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $225,643 - $264,368	-1,063 Reduced 6.19%	16,121 $3.43 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $100,439 - $111,430	-430 Reduced 2.44%	17,184 $4.19 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $10,873 - $12,671	-49 Reduced 0.28%	17,614 $4.38 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $412,420 - $491,119	1,906 Added 12.1%	17,663 $4.06 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $150,645 - $167,529	-642 Reduced 3.91%	15,757 $4.01 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $872,144 - $1.07 Million	4,409 Added 36.77%	16,399 $3.87 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $440,291 - $583,947	2,416 Added 25.24%	11,990 $2.43 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $107,092 - $137,651	566 Added 6.28%	9,574 $2.31 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $723,775 - $867,233	4,157 Added 85.69%	9,008 $1.74 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $77,182 - $90,474	-463 Reduced 8.71%	4,851 $894,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $15,193 - $17,125	84 Added 1.61%	5,314 $1.01 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $427,803 - $499,383	-2,398 Reduced 31.44%	5,230 $1.02 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $111,729 - $125,960	603 Added 8.58%	7,628 $1.58 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $82,360 - $92,508	496 Added 7.6%	7,025 $1.3 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $113,856 - $133,056	-672 Reduced 9.33%	6,529 $1.11 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $3,375 - $3,771	-20 Reduced 0.28%	7,201 $1.25 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $46,339 - $52,907	-277 Reduced 3.69%	7,221 $1.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,498	7,498 $1.29 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Amgen Inc Transaction History